Target Audience: This activity is designed for administrative staff, counselors, interprofessional teams, nurses, pharmacists, physician assistants, physicians, psychologists, and social workers . This activity is accredited for nurses, pharmacists, physician assistants, physicians, social workers, and the healthcare team.

Webinar Description: As the opioid use crisis continues to progress, communities across the country are now being faced with additional dangers such as the misuse of Xylazine, a powerful sedative commonly used for animals in the drug supply. Recent studies indicate these potent substances when used with opioids increase overdose risk and complicates treatment and long-term healthcare. Join us today as we discuss the history and context of Xylazine and opioid use as well as options for treatment and care.

Educational Objectives:

• Discuss the prevalence of xylazine and its relevance to opioid use disorder.
• Describe medical issues associated with xylazine use and effective strategies to address these.
• Examine treatment options for xylazine use.

Continuing Education information:

In support of improving patient care, this activity has been planned and implemented by the National Council for Mental Wellbeing and the American Academy of Addiction Psychiatry. American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Designation Statement

American Academy of Addiction Psychiatry designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Designation Statement

American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider #4008192. This activity is approved for up to 1 Nursing Contact Hours.

PA Designation Statement

American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for a maximum of 1AAPA Category 1 CME credits. Approval is valid until 09/01/2027. PAs should only claim credit commensurate with the extent of their participation.

Social Work Designation Statement

As a Jointly Accredited Organization, American Academy of Addiction Psychiatry (AAAP) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. AAAP maintains responsibility for this course. Social workers completing this course receive 1 continuing education credits.

Pharmacy Designation Statement 

This course has been approved for 1 hour of pharmacy continuing education credits. The approval number issued is Universal Activity Number: UAN JA4008192-9999-24-040-H01-P.

Interprofessional Continuing Education (IPCE) Designation Statement

This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education credits for learning and change.

Other Health Professionals

Participants will receive a Certificate of Attendance stating this program is designated for 1 AMA PRA Category 1 Credits™.